Bicara Therapeutics Inc. Common Stock (NASDAQ: BCAX) — Healthcare · Share Price, Chart & Market Data
About: Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $22.65 (-0.83%)
BCAXBicara Therapeutics Inc. Common Stock
Loading watchlist status…
Trade BCAX now
Bicara Therapeutics Inc. Common Stock share price
BCAX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 10:43 am GMT+0
BCAX price performance
-1.99%
5D
23.299%
1M
38.278%
YTD
52.937%
1Y
BCAX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 10:43 am GMT+0
BCAX details
BCAX Market Signals